Twitter | Search | |
Acceleron Pharma
Clinical stage biopharma focused on engaging the body's ability to rebuild and repair its own cells and tissues. Review our guidelines:
241
Tweets
134
Following
782
Followers
Tweets
Acceleron Pharma Nov 13
We’re looking forward to attending the 60th American Society of Hematology Annual Meeting (ASH) from Dec. 1-4 in San Diego, CA.
Reply Retweet Like
Acceleron Pharma Nov 9
Don’t miss it! We’re hosting a Pulmonary Arterial Hypertension R&D Deep Dive Event next Friday, Nov. 16. For webcast details, click here:
Reply Retweet Like
Acceleron Pharma Nov 7
We'll be presenting preclinical data on sotatercept in Pulmonary Arterial Hypertension, or , at the 2018 American Heart Association Scientific Session. Presentation details here:
Reply Retweet Like
Acceleron Pharma Nov 6
Ever wonder what it’s like to work at ? Check out this video to learn more about us!
Reply Retweet Like
Acceleron Pharma Nov 2
November is Month. is a rare, life-threatening blood vessel disorder for which we are conducting a Ph 2 trial [] w/ our pulmonary product candidate that has the potential to be a new disease-modifying therapy
Reply Retweet Like
Acceleron Pharma Nov 1
Phase 3 results from the BELIEVE trial will be shared during an oral presentation at
Reply Retweet Like
Acceleron Pharma Nov 1
We’re thrilled that Phase 3 results from the MEDALIST trial will be presented during the Plenary Scientific Session at
Reply Retweet Like
Acceleron Pharma Nov 1
We’re looking forward to attending the 60th American Society of Hematology Annual Meeting (ASH) from Dec. 1-4 in San Diego, CA.
Reply Retweet Like
Acceleron Pharma Nov 1
Today we announced that Phase 3 results from the MEDALIST and BELIEVE trials will be presented at the 60th American Society of Hematology (ASH) Annual Meeting
Reply Retweet Like
Acceleron Pharma Oct 30
Tune in to our 3Q 2018 webcast & conference call today @ 4:30pm EDT here:
Reply Retweet Like
Acceleron Pharma Oct 25
In recognition of , we were honored to host an MDS patient, caregiver, and representative of the MDS Foundation, each of whom discussed the MDS journey from their unique points of view
Reply Retweet Like
Acceleron Pharma Oct 25
Today is . Help us spread the word in support of patients with this debilitating blood disease
Reply Retweet Like
Acceleron Pharma Oct 23
Catch our 3Q 2018 webcast & conference call on Oct. 30th @ 4:30pm EDT. More info here:
Reply Retweet Like
Acceleron Pharma Oct 18
is one of the most common forms of muscular dystrophy in adults & children, yet there are no treatments. Every day, scientists are working toward developing new treatments for these patients
Reply Retweet Like
Acceleron Pharma Oct 16
We’re excited to announce that we’ll be hosting a deep dive educational event next month on along w/ leading clinicians & researchers. Webcast details here:
Reply Retweet Like
Acceleron Pharma Oct 9
Did you know that although is a blood disorder, it can affect the immune system, too? When the spleen struggles to make enough blood cells, it can’t fight infections as efficiently
Reply Retweet Like
Acceleron Pharma Oct 3
We will be presenting @ the 23rd International Annual Congress of the World Muscle Society in Mendoza, Argentina today @ 4:00 pm EST/ 5:00 pm ART. View posters here:
Reply Retweet Like
Acceleron Pharma Oct 2
Don't miss our webcast today @ 9:30AM from Roundtable Series: Rare Disease and Immuno-oncology roundtable. More info. here:
Reply Retweet Like
Acceleron Pharma Sep 27
We'll be presenting ACE-083 data in & next month 's 23rd International Annual Congress. Presentation details here:
Reply Retweet Like
Acceleron Pharma Sep 25
At , we are focused on harnessing the power of the TGF-beta superfamily and its role in cellular growth and repair. Learn more here:
Reply Retweet Like